CME Group Inc
SWB:MX4A
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
CME Group Inc
SWB:MX4A
|
US |
|
C
|
Capital One Financial Corp
DUS:CFX
|
US |
|
P
|
PTC Therapeutics Inc
XBER:BH3
|
US |
|
M
|
Macquarie Group Ltd
XBER:4M4
|
AU |
|
K
|
KLA Corp
F:KLA
|
US |
|
V
|
Vail Resorts Inc
F:VAI
|
US |
|
L
|
Lockheed Martin Corp
DUS:LOM
|
US |
|
Cbrain A/S
CSE:CBRAIN
|
DK |
|
N
|
Newmont Corporation
F:NMM
|
US |
|
K
|
Kering SA
XMUN:PPX
|
FR |
Wall St Price Targets
MX4A Price Targets Summary
CME Group Inc
According to Wall Street analysts, the average 1-year price target for MX4A is 270.79 EUR with a low forecast of 201.39 EUR and a high forecast of 321.33 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is MX4A's stock price target?
Price Target
270.79
EUR
According to Wall Street analysts, the average 1-year price target for MX4A is 270.79 EUR with a low forecast of 201.39 EUR and a high forecast of 321.33 EUR.
What is the Revenue forecast for CME Group Inc?
Projected CAGR
-13%
Over the last 13 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 3 years is -13%.
What is the Operating Income forecast for CME Group Inc?
Projected CAGR
-17%
Over the last 13 years, the compound annual growth rate for Operating Income has been 14%. The projected CAGR for the next 3 years is -17%.
What is the Pre-Tax Income forecast for CME Group Inc?
Projected CAGR
7%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 9%. The projected CAGR for the next 3 years is 7%.
What is the Net Income forecast for CME Group Inc?
Projected CAGR
7%
Over the last 13 years, the compound annual growth rate for Net Income has been 12%. The projected CAGR for the next 3 years is 7%.
